ZP Therapeutics

ZP Therapeutics is the commercialization division of Zuellig Pharma, a leading healthcare services provider in Asia. The company acts as a strategic partner for multinational pharmaceutical and biotech firms, providing end-to-end solutions for market entry and growth in the Asia-Pacific region. Their core services include market access, regulatory affairs, sales, marketing, and distribution across more than 13 Asian markets. ZP Therapeutics is well-known for its role in distributing high-profile products, such as the Moderna COVID-19 vaccine, and managing portfolios in therapeutic areas like oncology and immunology. By combining deep local market expertise with a robust distribution infrastructure, the company ensures that innovative healthcare solutions reach patients efficiently.